MedTrace Logo

Palm Tocotrienols in Chronic Hemodialysis (Malaysia) (PATCH)

NCT02913690 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 336

Last updated 2020-05-21

No results posted yet for this study

Summary

This study aims to determine if tocotrienol rich fraction (TRF) supplementation can improve markers of inflammation, oxidative stress and blood lipids in Malaysian hemodialysis (HD) patients.

Conditions

  • Chronic Kidney Failure

Interventions

DIETARY_SUPPLEMENT

Placebo

2 x 150mg capsules daily

DIETARY_SUPPLEMENT

TRF

2 x 150mg capsules daily

Sponsors & Collaborators

  • Universiti Putra Malaysia

    collaborator OTHER

  • Malaysia Palm Oil Board

    collaborator OTHER_GOV

  • PEMANDU

    collaborator UNKNOWN

  • National Kidney Foundation, United States

    collaborator OTHER

  • Ministry of Health, Malaysia

    collaborator OTHER_GOV

  • Wayne State University

    lead OTHER

Principal Investigators

  • Tilakavati Karupaiah, PhD · National University of Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2020-06-30
Completion
2020-12-14

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02913690 on ClinicalTrials.gov